| Catelog# |
Product |
CAS# |
Formula |
Purity(%) |
Inquiry |
First Page Previous Page [2729] [2730] [2731] 2732 [2733] [2734] [2735] [2736] Next Page Last Page Total 76996 items, Total 3080 Page Goto
| 2A-1181686 |
ACRYLIC ACID DICYCLOPENTANYL ESTER |
7398-56-3 |
C13H18O2 |
98.00% |
Inquiry |
| 2A-1181689 |
2,5-DICHLOROTHIOPHENE |
173777-89-4 |
|
0% |
Inquiry |
| 2A-1181690 |
THIOPHENE-3,4-DICARBOXYLIC ACID |
6007-85-8 |
|
0% |
Inquiry |
| 2A-1181691 |
4,6-DibroMothieno[3,4-c]furan-1,3-dione |
1015423-45-6 |
|
0% |
Inquiry |
| 2A-1181692 |
2,5-DibroMothiophene-3,4-dicarboxylic acid |
190723-12-7 |
|
0% |
Inquiry |
| 2A-1181693 |
ACTH (1-10) |
2791-05-1 |
|
0% |
Inquiry |
| 2A-1181694 |
ACTH (1-13) |
22006-64-0 |
|
0% |
Inquiry |
| 2A-1181696 |
MET-GLU-HIS-PHE-ARG-TRP-GLY |
4037-01-8 |
|
0% |
Inquiry |
| 2A-1181697 |
CLIP |
53917-42-3 |
|
0% |
Inquiry |
| 2A-1181698 |
ADRENOCORTICOTROPIC HORMONE RAT |
77465-10-2 |
|
0% |
Inquiry |
| 2A-1181699 |
ACTH (1-16) |
5576-42-1 |
|
0% |
Inquiry |
| 2A-1181700 |
ACTH (1-17) |
7266-47-9 |
|
0% |
Inquiry |
| 2A-1181700 |
ACTH (1-17) |
7266-47-9 |
|
0% |
Inquiry |
| 2A-1181702 |
H-ALA-ARG-LEU-ASP-VAL-ALA-SER-GLU-PHE-ARG-LYS-LYS-TRP-ASN-LYS-TRP-ALA-LEU-SER-ARG-NH2 |
150238-87-2 |
|
0% |
Inquiry |
| 2A-1181703 |
AMYLIN (8-37) (HUMAN) |
135702-23-7 |
|
0% |
Inquiry |
| 2A-1181704 |
AMYLIN (1-13) (HUMAN) |
198328-30-2 |
|
0% |
Inquiry |
| 2A-1181705 |
ANGIOTENSIN II ANTIPEPTIDE |
121379-63-3 |
|
0% |
Inquiry |
| 2A-1181706 |
ANGIOTENSIN III |
100900-06-9 |
|
0% |
Inquiry |
| 2A-1181707 |
ANGIOTENSIN III ANTIPEPTIDE |
133605-55-7 |
|
0% |
Inquiry |
| 2A-1181708 |
ANGIOTENSIN I/II (3-8) |
23025-68-5 |
|
0% |
Inquiry |
| 2A-1181709 |
(2,4,6-trimethoxyphenyl)methanethiol |
212555-23-2 |
|
0% |
Inquiry |
| 2A-1181710 |
Ethyl 2-(3-broMoquinolin-6-yl)acetate |
1393353-34-8 |
|
0% |
Inquiry |
| 2A-1181711 |
3-Methyl-7H-purin-6(3H)-one |
1006-11-7 |
|
0% |
Inquiry |
| 2A-1181712 |
2-Methoxy-methylphenol |
5635-98-3 |
|
0% |
Inquiry |
| 2A-1181713 |
1,1,1-TRIFLUORO-2,3-EPOXYPROPANE |
130025-34-2 |
|
0% |
Inquiry |
| |
|
|
|
